Aurora Cannabis ACB
NASDAQ ACB
$3.94 +0.13 (+3.41%)
At close: Aug 21, 2026 · 4:00 PM EDT

Aurora Cannabis (ACB) Cash from Discontinued Operations (2018 - 2026)

Aurora Cannabis (ACB) posted quarterly Cash from Discontinued Operations of 9410000.0 for Q1 2026, down 1128.6% year-over-year from 914833.97 in Q1 2025, and down 198.88% quarter-over-quarter from 9517000.0 in Q4 2025.

Aurora Cannabis (ACB) Cash from Discontinued Operations (2018 - 2026) Analysis & Trends

Aurora Cannabis (ACB) has reported Cash from Discontinued Operations for 9 consecutive years, with 9410000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Discontinued Operations fell 1128.6% year-over-year to 9410000.0; the TTM figure through Mar 2026 stood at 28180088.79 (up 143.83% YoY), while the FY2026 annual figure was 4144075.95, down 186.99% from the prior year.
  • Cash from Discontinued Operations retreated to 9410000.0 in Q1 2026 per ACB's latest filing, from 9517000.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 28839000.0 in Q4 2024 and bottomed at 30882000.0 in Q3 2023.
  • Historically, Cash from Discontinued Operations has averaged 3547598.9 across 5 years, with a median of 4333234.88 in 2022.
  • Annual changes were most pronounced in 2022 — Cash from Discontinued Operations tumbled 1864.71% — and 2024, when it surged 647.85%.
  • Aurora Cannabis' Cash from Discontinued Operations stood at 7811997.98 in 2022, then surged by 32.62% to 5264000.0 in 2023, then soared by 647.85% to 28839000.0 in 2024, then slumped by 67.0% to 9517000.0 in 2025, then plunged by 198.88% to 9410000.0 in 2026.
  • Business Quant data shows ACB's Cash from Discontinued Operations at 9410000.0 in Q1 2026, 9517000.0 in Q4 2025, and 765911.21 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Aurora Cannabis 243.01 Mn 170.70 Mn 25.75 Mn -7.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.41 Mn
Mar 31, 2026 -9.41 Mn
Dec 31, 2025 9.52 Mn
Dec 31, 2025 9.52 Mn
Mar 31, 2025 -765,911.21
Mar 31, 2025 -765,911.21
Dec 31, 2024 28.84 Mn
Dec 31, 2024 28.84 Mn
Sep 30, 2024 -24.89 Mn
Sep 30, 2024 -24.89 Mn
Jun 30, 2024 8.38 Mn
Jun 30, 2024 8.38 Mn
Mar 31, 2024 -457,141.74
Mar 31, 2024 -457,141.74
Dec 31, 2023 -5.26 Mn
Dec 31, 2023 -5.26 Mn
Sep 30, 2023 -30.88 Mn
Sep 30, 2023 -30.88 Mn
Dec 31, 2022 -7.81 Mn
Dec 31, 2022 -7.81 Mn